Skip to content

A Study on the Treatment of Chronic Pain Using an Implantable Spinal Cord Stimulation System

A Study on the Treatment of Chronic Pain Using an Implantable Spinal Cord Stimulation System

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110248
Enrollment
Unknown
Registered
2025-10-11
Start date
2025-10-31
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain, persistent and stubborn pain in the trunk and limbs

Interventions

Group B:First administer open-loop SCS stimulation for one month, followed by closed-loop stimulation for one month.
Group A:First administer closed-loop SCS stimulation for one month, followed by open-loop stimulation for one month.

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients with chronic pain who have undergone at least 3 months of conservative treatment with unsatisfactory or ineffective results; 2.Visual Analog Scale (VAS) score remains consistently greater than 6 for 3 days. 3.Age >=18 years old, no gender restrictions; 4.Take pain medication consistently for at least 28 days. 5.Capable of fulfilling the requirements for follow-up and questionnaire evaluation; 6.Voluntarily participate in clinical research and be able to sign an informed consent form;

Exclusion criteria

Exclusion criteria: 1.Pregnant women, breastfeeding women, women of childbearing age who are planning to conceive or are not using reliable contraception; 2.Patients with cognitive impairment (MoCA score >=26; add 1 point if education level <=12 years), severe depression that is untreatable, or inability to cooperate with surgery and programming procedures. 3.Severe dependence on drugs, alcohol, or illegal substances; 4.Local infection or active systemic infection at the anticipated surgical site; 5.The implantation site must undergo diathermy therapy. 6.Factors affecting SCS surgery are present in the spinal cord and spine, making SCS surgery unsuitable for certain patients. 7.An implantable drug pump and/or another implantable device, such as a pacemaker, defibrillator, cochlear implant, or other neurostimulator, has been placed. 8.Bleeding complications or coagulation disorders; 9.Metastatic malignant tumors or untreated localized malignant tumors; 10.Life expectancy is less than one year. 11.Unwilling or unable to cooperate with postoperative follow-up; 12.Researchers deem it inapplicable.

Design outcomes

Primary

MeasureTime frame
Improvement in pain compared to preoperative levels;

Secondary

MeasureTime frame
Programmed Control and Neurophysiological Characteristics;Pain medication dosage;Excessive stimulation intensity;Sleep Assessment;

Countries

China

Contacts

Public ContactLiqiang Yang

Xuanwu Hospital Capital Medical University

yangliqiangxwpain@outlook.com+86 10 8319 8981

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026